drugset / Trial / NCT02784288

Phase II Treatment Stratification Trial Using Neck Dissection-Driven Selection to Improve Quality of Life for Low Risk Patients With HPV+ Oropharyngeal Squamous Cell Cancer

NCT02784288 ↗

Phase 2 Completed 40 enrolled University of Michigan Rogel Cancer Center
NaSingle-groupOpen-labelTreatment

Summary

Investigators will determine whether a treatment paradigm of up-front neck dissection, to more accurately pathologically stage patients, minimizing the number of treatment modalities in patients with low risk oropharyngeal squamous cell carcinoma, can improve quality of life.

Timeline

Start
2016-10-31
Primary completion
2020-07-10
Completion
2022-07-12

Drugs

EvaluationDrugModalityDoseRoute
Background Carboplatin Small molecule — —
Background Paclitaxel Small molecule — —